This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Cheol Hyoung Park: Innovator in Neurodegeneration Treatment
Introduction
Cheol Hyoung Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative solutions to combat neuron apoptosis.
Latest Patents
Cheol Hyoung Park's latest patents include a pharmaceutical composition designed to inhibit apoptosis of neurons or neurodegeneration. This composition effectively prevents or treats diseases related to the apoptosis of neurons, showcasing his commitment to advancing medical science. The formulation aims to provide therapeutic benefits for conditions that lead to neurodegeneration.
Career Highlights
Park is associated with SK Biopharmaceuticals Co., Ltd., a company known for its dedication to developing innovative treatments. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to advancements in neuroprotective therapies.
Collaborations
Some of his notable coworkers include Jin Yong Chung and Ji Won Lee, who collaborate with him on various projects aimed at enhancing the efficacy of neuroprotective treatments.
Conclusion
Cheol Hyoung Park's contributions to the field of pharmaceuticals, particularly in neurodegeneration, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile